Pharma Journalist - Page 57 of 923 -

Gilead Completes $7.8 Billion Arcellx Acquisition Deal

EU Approves Rhapsido for Chronic Hives Treatment

Lilly to Acquire Ajax in $2.3 Billion Deal

Rocket Pharma’s RP-A601 Gene Therapy Granted FDA RMAT Designation for PKP2-ACM

Aldeyra’s Dry Eye Drug NDA Accepted for FDA Review

Astellas Partners with Korea’s KISED to Support Drug-Discovery Startups

ENHERTU Plus Pertuzumab Granted U.S. Breakthrough Therapy Status for HER2+ Metastatic Breast Cancer

AlzeCure’s ACD440 Pain Therapy Receives FDA Orphan Drug Designation

Sanofi’s SAR446597 Granted FDA Fast Track for Geographic Atrophy in AMD

Endeavor BioMedicines’ Taladegib Granted Orphan Drug Status in U.S. and EU for IPF

FDA Approves GSK’s Shingrix in Prefilled Syringe Format

Thermo Fisher and Sanofi Expand U.S. Drug Manufacturing Partnership

Repare Therapeutics Signs Exclusive Global License Deal with Debiopharm for Lunresertib